Zobrazeno 1 - 10
of 20
pro vyhledávání: '"VTM Hungria"'
Autor:
VTM Hungria, D Trufelli, K Nakajima, R Gaiolla, K Galvez, G Remaggi, R Bitterncourt, A Maiolino, N Schutz, G Quintero
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S247
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51cba869016bfd6f5703957cc90b2451
https://doi.org/10.1016/j.htct.2022.09.417
https://doi.org/10.1016/j.htct.2022.09.417
Autor:
Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK., Macro M; CHU de Caen Normandie, Caen, France., Davies FE; Perlmutter Cancer Center, NYU Langone, New York City, New York, USA., Abonour R; Indiana University School of Medicine, Indianapolis, Indiana, USA., van Rhee F; University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, USA., Hungria VTM; Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Silar J; Institute of Biostatistics and Analyses, Ltd, Brno, Czech Republic., Enwemadu V; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 190-200. Date of Electronic Publication: 2024 Apr 23.
Autor:
de Souza CA; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil. Electronic address: carmino@unicamp.br., Rego EM; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Ribeiro GN; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil., Magalhães SMM; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil., da Silva CAR; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Federal de São Paulo (UNIFESP), Sao Paulo, SP, Brazil., Passos LNDM; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Fundação de Hematologia e Hemoterapia do Amazonas (HEMOAM), Manaus, AM, Brazil., Covas DT; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Hemocentro de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil., Tavares RS; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Hospital das Clínicas da Universidade Federal de Goiás (HC UFG), Goiania, GO, Brazil., Hungria VTM; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil., Crusoé EQ; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil., Marques JFC Jr; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil., Chiattone CS; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP, Brazil., Langhi D Junior; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Neto JVP; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil., Laforga VP; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Centro de Hematologia e Hemoterapia do Paraná (Hemepar), Curitiba, PR, Brazil., Maiolino A; Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), São Paulo, SP, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Publikováno v:
Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2024 Jul-Sep; Vol. 46 (3), pp. 219-220. Date of Electronic Publication: 2024 May 26.
Autor:
Malard F; Sorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France. florent.malard@inserm.fr., Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada., Terpos E; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Moukalled N; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Hungria VTM; Department of Hematology, Clinica São Germano, São Paulo, Brazil., Manier S; Department of Hematology, Lille University Hospital and INSERM UMR-S1277 and CNRS UMR9020, Lille, France., Mohty M; Sorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France. mohamad.mohty@inserm.fr.
Publikováno v:
Nature reviews. Disease primers [Nat Rev Dis Primers] 2024 Jun 27; Vol. 10 (1), pp. 45. Date of Electronic Publication: 2024 Jun 27.
Autor:
Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: mdimop@med.uoa.gr., Hungria VTM; Department of Hematology, Clinica São Germano, São Paulo, Brazil., Radinoff A; Department of Clinical Haematology, University Hospital St Ivan Rilski EAD, Sofia, Bulgaria., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Mikala G; Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary., Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil., Maiolino A; Instituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil., Pappa V; Second Department of Internal Medicine and Research Unit, Haematology Unit, University General Hospital Attikon, Athens, Greece., Chraniuk D; Department of Haematology, Wojewodzki Szpital Zespolony, Torun, Poland., Osipov I; VA Almazov National Medical Research Centre, Saint Petersburg, Russia., Leleu X; Haematology, PRC, CHU Poitiers, Poitiers, France., Low M; Monash Haematology, Monash Health, Monash University, Clayton Campus, Clayton VIC, Australia., Matsumoto M; Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan., Sule N; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Li M; Oncology Clinical Development, GSK, Upper Providence, PA, USA., McKeown A; Oncology Clinical Development, GSK, Stevenage, UK., He W; Oncology Biostatistics, GSK, Waltham, MA, USA., Bright S; Pharmacovigilance, GSK, Upper Providence, PA, USA., Currie B; Patients Centered Outcomes, GSK, Rockville, MD, USA., Perera S; Value Evidence and Outcomes, GSK, London, UK., Boyle J; Global Clinical Operations, GSK, London, UK., Roy-Ghanta S; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Opalinska J; Oncology Clinical Development, GSK, Upper Providence, PA, USA., Weisel K; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Oct; Vol. 10 (10), pp. e801-e812.
Autor:
Viol Ferreira Lopes MA; Santa Casa de Misericórdia de São Paulo, SP, Brazil. Electronic address: maricyviol@gmail.com., Higashi F; Santa Casa de Misericórdia de São Paulo, SP, Brazil; Germano Clinic, São Paulo, SP, Brazil., Crusoe EQ; Universidade Federal da Bahia (UFBA), BA, Salvador, Brazil., Peres ALM; Germano Clinic, São Paulo, SP, Brazil., Cury P; Germano Clinic, São Paulo, SP, Brazil., Hungria VTM; Santa Casa de Misericórdia de São Paulo, SP, Brazil; Germano Clinic, São Paulo, SP, Brazil.
Publikováno v:
Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2023 Apr-Jun; Vol. 45 (2), pp. 259-265. Date of Electronic Publication: 2022 Aug 26.
Autor:
Thompson MA; Aurora Cancer Care, Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI,. Electronic address: michael.thompson@tempus.com., Boccadoro M; Division of Hematology, University of Torino, Torino, Italy., Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France., Vela-Ojeda J; Department of Hematology, UMAE Hospital de Especialidades Centro Medico La Raza IMSS, Mexico City, Mexico., van Rhee F; University of Arkansas for Medical Sciences, Little Rock, AR., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO., Usmani SZ; Levine Cancer Institute, Charlotte, NC., Hájek R; Department of Hemato-oncology, University Hospital Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK., Abonour R; Indiana University School of Medicine, Indianapolis, IN., Armour M; Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia., Morgan KE; Myeloma Patients Europe, Brussels, Belgium., Yeh SP; China Medical University Hospital, Taichung City, P.R.China., Costello CL; University of California San Diego, La Jolla, CA., Berdeja JG; Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN., Davies FE; Perlmutter Cancer Center, NYU Langone, New York, NY., Zonder JA; Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI., Lee HC; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Omel J; The Central Nebraska Myeloma Support Group, Grand Island, NE., Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health Monash University, Melbourne, Australia., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hungria VTM; Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Fu C; First Affiliated Hospital, Soochow University, Suzhou Jiangsu, P.R.China., Ferrari RH; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Chari A; Department of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07.
Autor:
Maiolino A; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Instituto Americas de Ensino e Pesquisa, Rio de Janeiro, RJ, Brazil. Electronic address: maiolino@hucff.ufrj.br., Crusoé EQ; Hospital Professor Edgar Santos da Universidade Federal da Bahia (HUPES-UFBA), Salvador, BA, Brazil., Martinez GA; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil., Braga WMT; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., de Farias DLC; A Beneficência Portuguesa de São Paulo (BP), São Paulo, SP, Brazil., Bittencourt RI; Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil., Neto JVP; Centro de Câncer de Brasilia (CETTRO), Brasilia, DF, Brazil., Ribeiro GN; Hospital das Clínicas da Universidade Federal de Minas Gerais (HC-UFMG), Belo Horizonte, MG, Brazil., Bernardo WM; Associação Médica Brasileira (AMB), São Paulo, SP, Brazil., Tristão L; Associação Médica Brasileira (AMB), São Paulo, SP, Brazil., Magalhaes RJP; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil., Hungria VTM; Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil.
Publikováno v:
Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2022 Jul-Sep; Vol. 44 (3), pp. 410-418. Date of Electronic Publication: 2022 Jul 20.
Autor:
Maiolino A; Faculdade de Medicina, Universidade Federal do Rio de Janeiro (FM UFRJ), Rio de Janeiro, RJ, Brazil; Americas Oncologia Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: maiolino@hucff.ufrj.br., Costa LJ; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Pasquini M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Crusoe EQ; Complexo Hospitalar Universitário Professor Edgard, Universidade Federal da Bahia (HUPES UFBA), Salvador, BA, Brazil; Rede D'or Oncologia, Salvador, BA, Brazil., Vigorito AC; Centro de Hematologia e Hemoterapia da Unicamp Universidade de Campinas, Unicamp (Hemocentro Unicamp), Campinas, SP, Brazil., Salvino MA; Complexo Hospitalar Universitário Professor Edgard, Universidade Federal da Bahia (HUPES UFBA), Salvador, BA, Brazil; Hospital San Rafael Rede D'or Oncologia, Salvador, BA, Brazil., Seguro FS; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil., Filho JS; AC Camargo Cancer Center, São Paulo, SP, Brazil., Hungria VTM; Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil; Clínica São Germano, São Paulo, SP, Brazil.
Publikováno v:
Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2021 Nov; Vol. 43 Suppl 2, pp. S30-S34.
Autor:
Laubach JP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: jacobp_laubach@dfci.harvard.edu., Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Mariz M; Portuguese Institute of Oncology, Porto, Portugal., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Spicka I; First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic., Hungria VTM; São Germano Clinic, São Paulo, Brazil., Shelekhova T; Saratov State Medical University, Saratov, Russia., Abdo A; University of São Paulo Faculty of Medicine Hospital, São Paulo, Brazil., Jacobasch L; Group practice Freiberg-Richter, Jacobasch, Illmer, Wolf, Dresden, Germany., Polprasert C; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Hájek R; Department of Hematooncology, University Hospital of Ostrava and Faculty of Medicine, Ostrava, Czech Republic., Illés Á; Department of Hematology, University of Debrecen, Faculty of Medicine, Debrecen, Hungary., Wróbel T; Wrocław Medical University, Wrocław, Poland., Sureda A; Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Beksac M; Ankara University, Ankara, Turkey., Gonçalves IZ; Fundacao Pio XII Barretos Cancer Hospital, Barretos, Brazil., Bladé J; Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain., Rajkumar SV; Mayo Clinic, Rochester, MN, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Spencer A; Alfred Hospital-Monash University, Melbourne, VIC, Australia., Maison-Blanche P; Bichat-Claude Bernard Hospital (Paris Nord Val de Seine University Hospitals), Paris, France., Moreau P; University Hospital Hotel-Dieu, Nantes, France., San-Miguel JF; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigaciones Sanitarias de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Jan; Vol. 22 (1), pp. 142-154. Date of Electronic Publication: 2020 Dec 07.